Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 22

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 22
---
 less than the maximum amounts set forth above. We may sell fewer than all of the securities
offered hereby, which may significantly reduce the amount of proceeds received by us, and investors in this offering will not receive
a refund in the event that we do not sell an amount of securities sufficient to support our continued operations, including our near-term
continued operations. Thus, we may not raise the amount of capital we believe is required for our operations in the short-term and may
need to raise additional funds, which may not be available or available on terms acceptable to us.

There is no public market for the warrants being offered in this offering.

The public offering price
for the securities will be determined by negotiations between us, the placement agent and prospective investors, and may not be indicative
of prices that will prevail in the trading market. We do not intend to apply to list the warrants on NASDAQ or any nationally recognized
trading system, and accordingly, there will be no trading market for such warrants. In the absence of an active public trading market:

| · | you may not be able to resell your securities at or above the public offering price; |

| · | the market price of our Depositary Shares may experience more price volatility; and |

| · | there may be less efficiency in carrying out your purchase and sale orders. |

| 15 |

Holders of Pre-Funded Warrants and Series L Warrants purchased in this offering will have no rights as Depositary Share holders until such holders exercise such Pre-Funded Warrants and Series L Warrants and acquire our Depositary Shares.

Until holders of Pre-Funded
Warrants and Series L Warrants acquire Depositary Shares upon exercise of such Pre-Funded Warrants and Series L Warrants, holders of Pre-Funded
Warrants and Series L Warrants will have no rights with respect to the Depositary Shares underlying such Pre-Funded Warrants and Series
L Warrants. Upon exercise of the Pre-Funded Warrants and Series L Warrants, as applicable, the holders will be entitled to exercise the
rights of an Depositary Share holder only as to matters for which the record date occurs after the exercise date.

The Pre-Funded Warrants and Series L Warrants are speculative in nature.

The Pre-Funded Warrants
and Series L Warrants do not confer any rights of Depositary Share ownership on their respective holders, such as voting rights or the
right to receive dividends, but rather merely represent the right to acquire Depositary Shares at